» Articles » PMID: 38178855

Assessing Medication Adherence and Their Associated Factors Amongst Type-2 Diabetes Mellitus Patients of Jazan Province, Saudi Arabia: A Single-center, Cross-sectional Study

Abstract

Background: The prevalence of type 2 diabetes mellitus (T2DM) globally is reaching epidemic proportions. By 2035, it is projected to increase to 417 million, which is of significant concern as T2DM represents the most oversized budget item in many healthcare systems, primarily due to the high rates of morbidity and mortality associated with the disease. The worldwide cost burden of T2DM has been inexorably growing. A key contributor to the remarkably high morbidity and mortality rates is poor glycemic control potentially associated with medication non-adherence.

Aim: The present research's main objective included assessing medication adherence among patients with T2DM in a single center in Jazan Province.

Methods: Three hundred nine patients with T2DM participated in a cross-sectional survey over three months (September to November 2022). The study participants comprised 50.8 % (females) and 49.2 % (males), with a mean age of 44.12 years (SD ± 12.70). A 31-item self-report questionnaire was used for data collection.

Results: Sixty-six percent of the sample were found to be adherent to their T2DM therapy. A positive association was noticed between the GMAS score and the participant's age (r = 0.24; p < 0.01). The participants' medication adherence was significantly associated with having age above 50 years ( 13.62;  0.001), residing in urban localities ( 21.37), being married ( 12.80 0.002), having glycated hemoglobin level more than 8 % ( 6.99) and taking between one to three medications per day ( 17.63).

Conclusion: The majority of T2DM patients in the present study were found adherent to their anti-diabetic medications, particularly older patients. Future studies should focus on exploring the reasons for the reported high adherence among older patients and non-adherence among younger patients, as this could facilitate the development of a strategy to enhance adherence.

Citing Articles

Longitudinal Trajectories of Antidiabetic Medication Adherence Over 5 Years From Treatment Initiation-A Swedish Nationwide Cohort Study.

Pazzagli L, Odsbu I, Cesta C, Bellocco R, Trolle Lagerros Y, Pasternak B Clin Transl Sci. 2025; 18(3):e70174.

PMID: 40022455 PMC: 11871106. DOI: 10.1111/cts.70174.


Hepatitis Associated with Consumption-A Single-Center Study.

Someili A, Mohrag M, Abdulrasak M J Clin Med. 2025; 14(4).

PMID: 40004737 PMC: 11855943. DOI: 10.3390/jcm14041206.


Predictors to Poor Quality of Life Among Patients with Heart Failure and Its Correlation with Their Medication Adherence: Finding for Healthcare Improvement and Follow-Up.

Alkubati S, Aleyadah H, Alboliteeh M, Alharbi A, Alsaif B, Alshammari B Patient Prefer Adherence. 2024; 18:2545-2557.

PMID: 39703933 PMC: 11656328. DOI: 10.2147/PPA.S503087.


Relationship Between Depression and Medication Adherence Among Chronic Disease Patients in the Middle East.

Alomar A, Khushaim R, Al-Ghanem S, Bin Jumaiah A, Albaqami S, Alleft L Cureus. 2024; 16(9):e69418.

PMID: 39403637 PMC: 11473096. DOI: 10.7759/cureus.69418.


Exploring patient's perspective of barriers to diabetic medication adherence in Jazan, Saudi Arabia, using the social determinants of health model.

Khardali A, Aladwani A, Alzahrani F, Madkhali O, Al Qahtani S, Qadri M SAGE Open Med. 2024; 12:20503121241271820.

PMID: 39161401 PMC: 11331575. DOI: 10.1177/20503121241271820.

References
1.
Jaam M, Ibrahim M, Kheir N, Hadi M, Diab M, Awaisu A . Assessing prevalence of and barriers to medication adherence in patients with uncontrolled diabetes attending primary healthcare clinics in Qatar. Prim Care Diabetes. 2017; 12(2):116-125. DOI: 10.1016/j.pcd.2017.11.001. View

2.
Itumalla R, Kumar R, Elabbasy M, Perera B, Torabi M . Structural Factors and Quality of Diabetes Health Services in Hail, Saudi Arabia: A Cross-Sectional Study. Healthcare (Basel). 2021; 9(12). PMC: 8701064. DOI: 10.3390/healthcare9121691. View

3.
Ewid M, Algoblan A, Elzaki E, Muqresh M, Al Khalifa A, Alshargabi A . Factors associated with glycemic control and diabetes complications in a group of Saudi patients with type 2 diabetes. Medicine (Baltimore). 2023; 102(38):e35212. PMC: 10519521. DOI: 10.1097/MD.0000000000035212. View

4.
Punnapurath S, Vijayakumar P, Platty P, Krishna S, Thomas T . A study of medication compliance in geriatric patients with chronic illness. J Family Med Prim Care. 2021; 10(4):1644-1648. PMC: 8144798. DOI: 10.4103/jfmpc.jfmpc_1302_20. View

5.
Bener A, Zirie M, Janahi I, Al-Hamaq A, Musallam M, Wareham N . Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes Res Clin Pract. 2009; 84(1):99-106. DOI: 10.1016/j.diabres.2009.02.003. View